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The 3* untranslated region (UTR) adjacent to the capsid gene is frequently included with the transgene in the construction
of capsid protein mediated virus resistant transgenic plants. Since ribonucleotide sequences within the 3* UTR are involved
in the initiation of viral replication, the presence of this sequence may encourage the participation of the transgene in RNA
recombination. Experiments were designed to explore the involvement of the 3* UTR of cowpea chlorotic mottle virus
(CCMV) in RNA recombination events between transgenes and challenging viruses. Nicotiana benthamiana was transformed
with CCMV transgenes consisting of the 3* two-thirds of the capsid gene and fragments of the associated 3* UTR lacking
the terminal 69, 83, or 214 nucleotides. Plants were inoculated with wild-type CCMV transcripts for RNAs 1 and 2 and a
movement defective RNA 3 transcript lacking the 3* third of the capsid gene. While no recombinant virus was detected in
plants expressing 3* deletion constructs, 3% of control transformants containing an identical segment of the capsid gene
with the complete 3* UTR yielded viable recombinant virus. These results suggest that RNA recombination between
transgenic RNA and viral RNA can be reduced significantly by omitting or disrupting the 3* UTR in the transgene. q 1996
Academic Press, Inc.
Virus resistant transgenic plants (VRTPs) acquire Cowpea chlorotic mottle bromovirus (CCMV) consists
of two monocistronic RNAs, 1 and 2, that encode replica-pathogen derived resistance through the constitutive ex-
pression of a segment of a plant virus genome including tion proteins and a dicistronic RNA 3. RNA 3 encodes
the putative movement protein, 3a, and capsid protein,the capsid (1), polymerase (2), or movement protein
genes (3, 4). One concern about the release of VRTPs to both of which are required for systemic movement (10).
Infectious transcripts produced from complementarythe environment is that recombination between the viral
transgene and a challenging virus could produce chime- DNA (cDNA) clones of these RNAs (14) infect legumes
systemically and produce a symptomless systemic infec-ric viruses with distinct properties.
RNA recombination appears to be a fundamental evolu- tion in Nicotiana benthamiana (Domin).
Using CCMV as a model system, we established thattionary mechanism of RNA viruses. Recombination occurs
when the viral replicase switches RNA templates during viral RNA transcribed in a transgenic plant is available
for recombination with challenging viruses (15). Whensynthesis of the complementary RNA strand and effectually
unites two previously distinct RNAs (5). Sequence analysis transgenic N. benthamiana expressing the 3* two-thirds
of the capsid gene and the complete 3* untranslatedprovides evidence of recombination in several animal RNA
viruses, bacteriophage (5), and plant RNA viruses (6, 7). region (UTR) of CCMV was inoculated with a CCMV sys-
temic movement defective mutant lacking the 3* third ofAdditionally, RNA recombination has been demonstrated
during reverse transcription between a cauliflower mosaic the capsid gene, 3% of the transformants became sys-
temically infected. Viable recombinant virus with a re-virus (CaMV) transgene and challenging CaMV inoculum
(8, 9). Both homologous recombination and aberrant ho- stored capsid gene was recovered in each case.
Inclusion of the 3* UTR in the transgenic message maymologous recombination have been recorded in bromovi-
ruses (10–12). In bromoviruses, nonhomologous recombi- influence the interaction between the transgenic RNA
and challenging viral RNA. Given the critical role of thenation is facilitated by heteroduplex formation during minus
strand synthesis (13). 3* UTR as the viral replicase binding site in bromoviruses
(16, 17) and other RNA viruses (18–20), this study was
undertaken to determine if disruption of the 3* UTR of a1 Present address: Agronomy Department, Purdue University, 1150
CCMV transgene would influence the formation of viableLilly Hall of Life Sciences, West Lafayette, IN 47907-1150.
recombinant viruses.2 To whom correspondence and reprint requests should be ad-
dressed. Fax: (517) 353-1926. E-mail: 22923MGR@MSU.edu. The three wild-type (WT) CCMV full-length cDNA clones
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richia coli strain JM101, plasmids were isolated by alka-
line lysis (22). Sequence analysis (Sequenase 2.0, U.S.
Biochemical, Cleveland OH) revealed a series of nested
deletions which removed from 20 to 250 nucleotides of
the 3* UTR. Analysis of the remainder of the 3* UTRs and
capsid genes indicated that no spurious mutations had
been introduced and that the marker mutations that dis-
tinguish pCC3AG1 from wild-type CCMV RNA 3 remained
intact. Three plasmids containing deletions of 69
(pCC3AG2D69), 83 (pCC3AG2D83), and 214 (pCC3AG-
2D214) nucleotides from the 3* terminus of the cDNA
insert (Fig. 1B) were selected
Restriction fragments produced by a StyI–HindIII di-
gest, cDNA nucleotides 1476–1477 and polylinker cleav-
age site, respectively, of the 3* deletion plasmids in-
cluded the 3* two-thirds of the capsid gene and the re-
maining 3* UTR. Binary transformation vector pGA643
(23) was digested with HindIII and treated with alkaline
phosphatase. In a two-step ligation process, the HindIII
end of the restriction fragment was ligated to the plasmid.
Incompatible sticky ends of the plasmid and insert were
filled with Klenow and blunt end ligated. This placed the
CCMV sequence between the 35S CaMV transcription
promoter and the termination sequences of the octopine-
type Ti plasmid pTi63 (23). The resulting plasmids,FIG. 1. Representation of constructs derived from pCC3AG1. (A) Full-
pGACCMVD69, pGACCMVD83, and pGACCMVD214,length CCMV RNA 3 cDNA clone pCC3AG1 is the parent clone for the
inoculum and transformation constructions. Genes are indicated by were mobilized into Agrobacterium tumefaciens strain
open boxes and UTRs by solid lines. The NotI site and a silent mutation, LBA4404 (24) by triparental mating using helper plasmid
denoted by the arrow, distinguish pCC3AG1 from wild-type CCMV RNA pRK2013 (25). N. benthamiana leaf explants were trans-
3. Appropriate restriction sites within the capsid gene, cp, are indicated.
formed, selected, and regenerated as described (15).RNA 3 inoculum transcribed from pCC3AG3 contains a deletion within
Transformation was confirmed by enzyme-linked im-the cp gene between SacII (1814–1815) and NotI (1933–1934). Plants
expressing transgenic cDNA with a complete 3* UTR served as a con- munosorbant assay (ELISA) for NPTII (5 Prime r 3 Prime,
trol. (B) The complete CCMV cp gene and 3* UTR are represented on Inc. Boulder, CO) and by Northern blot hybridization with
the first line; numerals indicate specific nucleotides. The deletion series a nick-translated (Boehringer Mannheim) 456-basepair
with the abbreviated 3* UTRs are shown below. Numbers prefixed by
StyI–NotI fragment from pCC3AG1. From 30 transformeddelta (D) indicate the extent of the 3* deletion. Gray areas indicate
plants, 1 independent transformant for each deletion wassequence shared by the transgenic insert and challenging inoculum.
selected for further study and propagated clonally by
either tissue culture or cuttings. Selected transformants
had NPTII ELISA absorbance values and transcript hy-and their corresponding infectious transcripts, designated
C1, C2, and C3, were described previously (14). C1 and bridization signals (Fig. 2) that were similar to those of
the control transformants and the transformants used inC2 were not modified for these experiments. Infectious
clone pCC3AG1 (Fig. 1A) contained a complete cDNA previous recombination experiments (15). Since a full-
length capsid protein was not expressed, all trans-copy of CCMV RNA 3 adjacent to a T7 RNA polymerase
promoter but differed from wild-type C3 by three intro- formants were susceptible to WT CCMV infection.
Transgenic plants were inoculated at the 5-leaf stageduced mutations (15). The RNA 3 deletion inoculum, AG3,
which lacked the 3* one-third of the capsid gene, was of development with C1, C2, and AG3. Control plants that
transcribe the 3* two-thirds of the capsid gene and a full-transcribed from pCC3AG3 (Fig. 1A) as described (15).
To generate the 3* UTR deletions, 1 mg of pCC3AG1 length 3* UTR (Fig. 1A) were inoculated similarly. Since
CCMV is symptomless on N. benthamiana, systemic in-was cut within the polylinker with PstI and XbaI and
digested at 307 with 3 units exonuclease III. Ten equal fections of noninoculated leaves were assessed by dot
blot assays with RA518, a probe specific for the 3* UTRaliquots were taken at 5-sec intervals. Plasmid termini
were filled with Klenow and plasmids were religated. of CCMV RNAs (10). Hybridization assays indicated that
of 156 (D69), 172 (D83), and 151 (D214) transgenicEnzymatic reactions followed published protocols (21)
and were conducted under conditions specified by the plants inoculated with C1, C2, and movement defective
AG3, none became systemically infected over the 4-supplier (Boehringer-Mannheim, Indianapolis, IN).
Following transformation and propagation in Esche- month screening period. In contrast, 3% (7 of 235) of
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transcript itself, in addition to the viral RNA. This may
increase the incidence of RNA recombination in two
ways:
First, initiation of replication on the transgenic tran-
script could result in the synthesis of a complete minus
strand RNA complementary to the transgenic viral tran-
script. In this case, both plus and the minus strand
copies of the transgene would be available for RNA
recombination.
Second, if replication is initiated on the 3* UTR of a
transgenic transcript, only one template switch would be
required to regenerate a complete viral RNA (Fig. 3A). In
contrast, if replication cannot initiate on the transgenic
insert, a minimum of two template switches is required
to restore complete viral RNA. In this case the replicase
complex must initiate synthesis on the challenging viral
RNA, switch to the viral transcript, and return to a viral
RNA to complete synthesis of a full-length viral RNA with
complete 3* and 5* termini (Fig. 3B). Thus the elimination
of the replication initiation site from the transgenic tran-FIG. 2. Northern blots of total RNA of transgenic plants. Equal quanti-
script may complicate the formation of viable recombi-ties of total RNA extracted from transgenic plants were separated in
a 1.0% denaturing agarose gel, Northern blotted to nylon membrane, nants significantly.
and probed with the StyI– NotI CCMV capsid gene fragment. Lanes 1– Assuming that replication initiates only on the chal-
4 contain total RNA from the following transformants: control plant 3- lenging inoculum, an alternative explanation is that the
57 with the complete 3* UTR, D69, D83, D214. The 697 ribonucleotide
shorter transgenic transcripts simply provide less RNAtranscript of 3-57 is denoted by the arrow.
for crossover to occur. However, in this case, we would
predict a correlation between the size of the deletion and
the recovery of recombinant virus.transformants expressing the 3* two-thirds of the capsid
gene plus the full-length 3* UTR became systemically In closely related brome mosaic bromovirus, the 3*
UTR of RNA 3 interacts with tRNA specific host enzymesinfected between 2 and 5 weeks postinoculation when
challenged with the same inoculum. Recovery of trans- (28) and may be involved with the recruitment of host
factors required for active replication. If the 3* UTR ofgenic marker mutations confirmed the recombinant ori-
gin of these systemic infections (data not shown). All CCMV plays a similar role, this region may target the
nontransgenic plants inoculated with wild-type tran-
scripts became systemically infected while plants inocu-
lated with buffer remained uninfected. None of the in-
fected plants showed symptoms which is consistent with
wild-type CCMV infection of N. benthamiana. Collectively,
these data suggested that RNA recombination had either
not occurred in the transformants with 3* UTR deletions
or recombination did not result in the restoration of viable
virus.
Although numerous reported VRTPs include the 3*
UTR, this region may not be required for resistance since
it is not a characteristic of all successful resistance con-
structs (26, 27). While it may provide stability to the tran-
script, we identified 3* deletion transformants with tran-
script quantities similar to those found in transformants
FIG. 3. Models for RNA recombination. CCMV RNA 3 deletion mutant
expressing the full-length 3* UTR (Fig. 2). Therefore, a is depicted undergoing recombination with the transgene. In A, the
complete UTR may be unnecessary for either transcript replication complex, RC, has initiated minus strand synthesis, dark line,
on the transgene with the full-length 3* UTR. One strand switch withinstabilization or resistance.
the shaded area to the inoculum permits synthesis of a full-length RNAThe lack of recombination in these experiments sug-
3 to be completed on the deletion mutant. In B, the deletion, D, in thegests that the 3* UTR plays a significant role in RNA
transgene disrupts the replication initiation site. Synthesis of a full-
recombination in transgenic plants. The presence of the length RNA requires initiation on the deletion inoculum, a switch to the
complete 3* UTR on transgenic transcripts may enable transgene and a second switch to the inoculum for completion of minus
strand.a viral replicase complex to initiate replication on the
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